Taro Tamaki

455 total citations
21 papers, 361 citations indexed

About

Taro Tamaki is a scholar working on Cancer Research, Surgery and Molecular Biology. According to data from OpenAlex, Taro Tamaki has authored 21 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 9 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Taro Tamaki's work include Cancer, Lipids, and Metabolism (9 papers), Lipoproteins and Cardiovascular Health (8 papers) and Cholesterol and Lipid Metabolism (4 papers). Taro Tamaki is often cited by papers focused on Cancer, Lipids, and Metabolism (9 papers), Lipoproteins and Cardiovascular Health (8 papers) and Cholesterol and Lipid Metabolism (4 papers). Taro Tamaki collaborates with scholars based in Japan. Taro Tamaki's co-authors include Nobuo Aoki, Akitada Ichinose, Masaki Kitahara, Yasushi Saitō, Fumiyasu Sato, Taro Aoki, Hideo Suzuki, Tatsuro Kanaki, Hiroyuki Yamazaki and Yoichi Sakata and has published in prestigious journals such as FEBS Letters, Phytochemistry and European Journal of Pharmacology.

In The Last Decade

Taro Tamaki

20 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taro Tamaki Japan 9 126 103 96 95 75 21 361
Sohei Tanabe Japan 14 32 0.3× 134 1.3× 134 1.4× 65 0.7× 209 2.8× 32 658
M. Berrozpe Spain 9 46 0.4× 198 1.9× 112 1.2× 83 0.9× 87 1.2× 12 456
T. Royo Spain 13 29 0.2× 162 1.6× 92 1.0× 46 0.5× 122 1.6× 24 474
Mahendra K. Patel United Kingdom 15 82 0.7× 73 0.7× 17 0.2× 47 0.5× 144 1.9× 29 457
MR Buchanan Canada 11 86 0.7× 95 0.9× 162 1.7× 60 0.6× 89 1.2× 23 507
MA Guccione Canada 12 129 1.0× 58 0.6× 273 2.8× 30 0.3× 110 1.5× 19 544
G J Gasic United States 4 42 0.3× 47 0.5× 154 1.6× 67 0.7× 68 0.9× 6 348
Xingwen Da China 11 51 0.4× 51 0.5× 37 0.4× 82 0.9× 201 2.7× 16 435
Tso‐Fu Wang Taiwan 13 67 0.5× 43 0.4× 53 0.6× 61 0.6× 135 1.8× 47 430
Mohammad Abdul Hai Siddique Japan 10 165 1.3× 62 0.6× 16 0.2× 58 0.6× 138 1.8× 20 380

Countries citing papers authored by Taro Tamaki

Since Specialization
Citations

This map shows the geographic impact of Taro Tamaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Tamaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Tamaki more than expected).

Fields of papers citing papers by Taro Tamaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Tamaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Tamaki. The network helps show where Taro Tamaki may publish in the future.

Co-authorship network of co-authors of Taro Tamaki

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Tamaki. A scholar is included among the top collaborators of Taro Tamaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Tamaki. Taro Tamaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Hideo, Hiroyuki Yamazaki, Taro Aoki, et al.. (2011). Hypolipidemic Effect of NK-104 and Other 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors in Guinea Pigs. Arzneimittelforschung. 51(1). 38–45.
2.
Suzuki, Hideo, Taro Aoki, Junji Kojima, et al.. (2011). Lipid-lowering and Antiatherosclerotic Effect of NK-104, a Potent 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor, in Watanabe Heritable Hyperlipidemic Rabbits. Arzneimittelforschung. 50(11). 995–1003. 3 indexed citations
3.
Aoki, Taro, Hiroyuki Yamazaki, Hideo Suzuki, et al.. (2011). Cholesterol-lowering Effect of NK-104, a 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitor, in Guinea Pig Model of Hyperlipidemia. Arzneimittelforschung. 51(3). 197–203. 4 indexed citations
4.
Ishii, Itsuko, et al.. (2008). Effect of Pitavastatin on Macrophage Cholesterol Metabolism. YAKUGAKU ZASSHI. 128(3). 357–363. 3 indexed citations
5.
Yamazaki, Hiroyuki, Hideki Fujino, Taro Tamaki, et al.. (2004). Pharmacological and pharmacokinetic features and clinical effects of pitavastatin (Livalo Tablet®). Folia Pharmacologica Japonica. 123(5). 349–362. 9 indexed citations
6.
Aoki, Taro, Hiroyuki Yamazaki, Hideo Suzuki, et al.. (2002). Triglyceride-lowering effect of pitvastatin in a rat model of postprandial lipemia. European Journal of Pharmacology. 444(1-2). 107–113. 17 indexed citations
7.
Aoki, Taro, Hideo Suzuki, Taro Tamaki, et al.. (2000). Effect of itavastatin on postprandial triglyceride levels and lymph chylomicron in rats. Atherosclerosis. 151(1). 50–50. 1 indexed citations
8.
Suzuki, Hideo, Hiroyuki Yamazaki, Taro Aoki, et al.. (2000). Hypolipidemic effect of itavastatin and other statins in guinea pigs. Atherosclerosis. 151(1). 51–51. 1 indexed citations
9.
Suzuki, Hideo, Taro Aoki, Taro Tamaki, et al.. (1999). Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs. Atherosclerosis. 146(2). 259–270. 59 indexed citations
10.
11.
12.
Yamamoto, Susumu, et al.. (1993). Urinary Thrombomodulin, Its Isolation and Characterization1. The Journal of Biochemistry. 113(4). 433–440. 15 indexed citations
13.
Tanaka, Masahiro, et al.. (1993). Study on the Glomerular Foam Cells in Stroke-prone SHR. EXPERIMENTAL ANIMALS. 42(2). 203–209. 1 indexed citations
14.
Tanabe, Sohei, Taro Tamaki, & Yasushi Wada. (1992). Sphingosine inhibits factor Xa-catalyzed prothrombin activation on the surface of cultured calf pulmonary artery endothelium perturbed by hydrogen peroxide. Thrombosis Research. 67(1). 115–122. 4 indexed citations
15.
Ichinose, Akitada, Taro Tamaki, & Nobuo Aoki. (1983). Factor XIII‐mediated cross‐linking of NH2‐terminal peptide of α2‐plasmin inhibitor to fibrin. FEBS Letters. 153(2). 369–371. 96 indexed citations
16.
Tamaki, Taro & Nobuo Aoki. (1981). Cross-linking of α2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. Biochimica et Biophysica Acta (BBA) - Enzymology. 661(2). 280–286. 85 indexed citations
17.
Tamaki, Taro, Yoichi Sakata, & Nobuo Aoki. (1981). Survival of transfused α2-plasmin inhibitor in a patient with its congenital deficiency. Thrombosis Research. 22(3). 281–286. 4 indexed citations
18.
Sakata, Yoichi, et al.. (1979). Calcium-dependent binding of α2-plasmin inhibitor to fibrin. Thrombosis Research. 16(1-2). 279–282. 9 indexed citations
19.
Yamasaki, Kazuo, Taro Tamaki, Ushio Sankawa, & Shoji Shibata. (1976). Biosynthesis of Paeonol. YAKUGAKU ZASSHI. 96(9). 1103–1106. 1 indexed citations
20.
Yamasaki, Kazuo, et al.. (1973). Participation of C6C1 unit in the biosynthesis of ephedrine in Ephedra. Phytochemistry. 12(12). 2877–2882. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sohei Tanabe Breakdown of academic impact, for papers by M. Berrozpe Breakdown of academic impact, for papers by T. Royo Breakdown of academic impact, for papers by Mahendra K. Patel Breakdown of academic impact, for papers by MR Buchanan Breakdown of academic impact, for papers by MA Guccione Breakdown of academic impact, for papers by G J Gasic Breakdown of academic impact, for papers by Xingwen Da Breakdown of academic impact, for papers by Tso‐Fu Wang Breakdown of academic impact, for papers by Mohammad Abdul Hai Siddique
Rankless by CCL
2026